PEGS Boston

31. August - 4. September 2020
Boston, MA, USA

Teilnehmer: Dr. Oliver Hill, VP Drug Discovery/Lead Optimization

Präsentation am 4. September, 15:10 Uhr: "HERA-GITRL: A Unique Hexavalent GITR Agonist for Cancer Immunotherapy"

 

ESMO Congress 2020

18.-22. September 2020
Madrid, Spanien

Teilnehmer: Dr. Andriy Krendyukov, VP Medical Affairs

 

Präsentationen und Poster von vergangenen Konferenzen

AACR Virtual Annual Meeting II

22.-24. Juni 2020

Poster #4460: Novel bispecific molecules combining HERA-CD40L with anti-CEA or with anti-PD-L1 for targeting

Poster #4529: Neutralization of pro-apoptotic CD95L by Asunercept/APG101 does not impair anti-tumor immune responses

Präsentation #1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies